Kawakami Mark — SEC Form 4 filings

SEC reporting owner CIK 2030709. 4 Form 4 filings on record with FilingPulse; latest filed 2025-05-12.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-08-20 to 2025-05-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcadia Biosciences, Inc. (RKDA)Chief Financial Officer42 legs · 1,400 sh · $3,1852

Form 4 filings — Kawakami Mark

FiledFormIssuerReported transactionsSource
2025-05-124Arcadia Biosciences, Inc. (RKDA)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2025-02-054Arcadia Biosciences, Inc. (RKDA)Purchase (P): 700 @ $2.49EDGAR
2024-08-214Arcadia Biosciences, Inc. (RKDA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-08-204Arcadia Biosciences, Inc. (RKDA)Purchase (P): 700 @ $2.06EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2030709 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →